NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Type 2 diabetes
Date of first enrollment	03/10/2005
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : KAD-1229 (mitiglinide) INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Efficacy, Safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	Not applicable
Gender	Both
Include criteria	Main Inclusion Criteria: - Type 2 diabetic outpatients, aged 20 years or older, who are treated with diet and stable dose of pioglitazone monotherapy. - HbA1c and post prandial glucose are within a certain range Main Exclusion Criteria: - Patients who require treatment with insulin. - Patients complicated with severe diabetic microangiopathy (neuropathy, retinopathy or nephropathy). - Patients complicated with severe cardiac disease, hepatic disease, renal disease or hypertension.
Exclude criteria